lung cancer non-small cell lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with (suspected) NSCLC without distant metastases and suspected metastatic nodal spread on PET or CT scan; or a non PET-avid or centrally located tumour or a peripheral tumour >3 centimeters diameter. Previous EBUS/EUS has shown negative biopsy results.
Exclusion criteria
Exclusion criteria: Not eligible are patients with: a) highly suspected bulky mediastinal nodal disease; b) high suspicion of single level N2-3 metastasis defined by specific PET and EBUS/EUS characteristics; c) suspected non-resectable N2 disease; d) insufficient comprehension of the dutch language.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary: unforeseen N2 rate. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary: a) health care utilization and costs; b) composite outcome of major morbidity plus 30-day mortality; c) overall and disease-free survival; d) disease-specific and generic quality of life. | — |
Countries
Netherlands